Page last updated: 2024-09-03

dihydroethidium and citric acid, anhydrous

dihydroethidium has been researched along with citric acid, anhydrous in 1 studies

Compound Research Comparison

Studies
(dihydroethidium)
Trials
(dihydroethidium)
Recent Studies (post-2010)
(dihydroethidium)
Studies
(citric acid, anhydrous)
Trials
(citric acid, anhydrous)
Recent Studies (post-2010) (citric acid, anhydrous)
30839911,8947834,366

Protein Interaction Comparison

ProteinTaxonomydihydroethidium (IC50)citric acid, anhydrous (IC50)
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
perilipin-5Homo sapiens (human)4.5885
perilipin-1Homo sapiens (human)3.708
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform aHomo sapiens (human)4.5885

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Faraci, FM; Gunnett, CA; Heistad, DD1

Other Studies

1 other study(ies) available for dihydroethidium and citric acid, anhydrous

ArticleYear
Interleukin-10 protects nitric oxide-dependent relaxation during diabetes: role of superoxide.
    Diabetes, 2002, Volume: 51, Issue:6

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Allopurinol; Animals; Arteries; Blood Glucose; Citric Acid; Diabetes Mellitus, Experimental; Endothelium, Vascular; Enzyme Inhibitors; Female; Fluorescent Dyes; Interleukin-10; Male; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitroprusside; Phenanthridines; Polyethylene Glycols; Superoxide Dismutase; Superoxides; Vasoconstrictor Agents; Xanthine Oxidase

2002